Raising over $10M in their Series B funding, Liberate Medical is revolutionizing the way we approach mechanical ventilation.
July 12, 2023
Introducing Liberate Medical, the pioneering startup in the medical device industry that is transforming respiratory care. With an impressive $10M raised in their Series B funding round and backed by Scientific Health Development, Liberate Medical is revolutionizing the way we approach mechanical ventilation. Founded by visionary Angus McLachlan and located in Crestwood, KY, Liberate Medical provides VentFree, a groundbreaking respiratory muscle stimulator. VentFree utilizes proprietary non-invasive neuromuscular electrical stimulation to contract the abdominal wall muscles in synchrony with exhalation during mechanical ventilation. This breakthrough approach aims to reduce abdominal muscle atrophy, potentially shortening the time needed for patients to be liberated from mechanical ventilation.
With therapy that can begin from day one, regardless of patient cooperation or sedation, VentFree offers a quick, simple, and effective solution. Preliminary results from a pilot randomized controlled trial show reduced mechanical ventilation duration and ICU length of stay for patients who received VentFree stimulation compared to a placebo. This innovative technology has the potential to decrease morbidity and mortality, improve quality of life, and bring significant cost savings for healthcare providers. Join founder Angus McLachlan and Scientific Health Development in the journey to reshape respiratory care with Liberate Medical.